CIONIC
CIONIC builds the FDA-cleared Neural Sleeve, an AI-powered wearable neurotech device using multi-electrode functional electrical stimulation to improve walking for individuals with neurological conditions including MS, stroke, cerebral palsy, and spinal cord injury, sold direct-to-consumer, through 1,500 prescribers, and via the VA channel.
- Company typePrivate
- Founded2020
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What CIONIC does
CIONIC (Cionic, Inc.) is a privately held neurotechnology company headquartered in Scotts Valley, California, that develops the FDA-cleared Neural Sleeve, a wearable bionic garment for individuals with neurological conditions affecting mobility, including multiple sclerosis, stroke, cerebral palsy, spinal cord injury, and traumatic brain injury. The company's core technology, MultiStim, combines functional electrical stimulation with continuous afferent stimulation and proprietary adaptive algorithms driven by on-device IMU kinematics and sEMG sensors; the system can interleave up to 12 independent pulse trains to simultaneously activate weak muscles and relax spastic muscles in real time. CIONIC monetizes through a hardware-plus-recurring-subscription model: a down payment plus monthly installments during Year 1 totaling $3,600 (single leg) or $6,200 (dual leg), transitioning to a $125-$200/month subscription for ongoing Mobility Specialist support, electrodes, and warranty, with a refurbished option at $875 and a side-exchange path for upgrades.
The company operates a multi-channel go-to-market combining direct-to-consumer e-commerce with a 30-second online assessment and virtual onboarding, a prescriber channel of 1,500 physicians and physical therapists nationwide, and a federal channel via its partnership with Lovell Government Services providing veterans access through the VA. CIONIC has raised approximately $35.25 million across five funding rounds through October 2023, with L Catterton (lead, 2023) and BlueRun Ventures (lead, 2022) as flagship investors. It has established clinical and research partnerships with Shirley Ryan AbilityLab, Stanford University, and the National MS Society, and has accumulated 2 million hours of real-world wear time and 500 million stimulated steps across its user base. The Neural Sleeve 2, cleared by the FDA in September 2025, expanded indications to include simultaneous muscle activation and spasm relaxation, and was named a TIME Best Invention of 2025 and Fast Company Most Innovative Company for 2026.
CIONIC firmographics
Firmographics- Name
- CIONIC
- Legal name
- Cionic, Inc.
- Website
- https://cionic.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CIONIC builds the FDA-cleared Neural Sleeve, an AI-powered wearable neurotech device using multi-electrode functional electrical stimulation to improve walking for individuals with neurological conditions including MS, stroke, cerebral palsy, and spinal cord injury, sold direct-to-consumer, through 1,500 prescribers, and via the VA channel.
- Ownership category
- akta.pro rank
CIONIC industry classification
Industry- Product category
- Wearable Neurotechnology / Medical Mobility Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)
- akta.pro secondary industries
- Assistive & Accessibility Input Devices (Switches, Adaptive Controllers, Braille Keyboards) (HDACAFAL), Wearable Computers (Industrial Smart Glasses/Wrist/Arm-Mount) (HDACALAH)
Keywords
Where CIONIC is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
CIONIC business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Neural Sleeve Hardware Sales: Sale of the Neural Sleeve wearable device, which includes the sleeve garment, control unit, and accessories. Customers pay a down payment followed by monthly installments over 12 months, then transition to subscription for ongoing support.
- Subscription Services: Ongoing monthly subscription after the first 12 months at $125/month for single leg or $200/month for dual leg. Includes Mobility Specialist support, electrode supply, and extended warranty coverage. Year 1 totals $3,600 (single) or $6,200 (dual).
- Refurbished Device Sales: One-time purchase option for prior-generation Neural Sleeves at $875, available through the Certified Refurbished Program. Includes 3 months of service with option to enroll in ongoing subscription.
- Professional Services: Mobility Specialist onboarding and follow-up sessions, Fit Confirmation appointments, and a la carte services for customers not on subscription plans.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Single Neural Sleeve - Year 1 |
| Subscription | Monthly | Dual Neural Sleeve - Year 1 |
| Subscription | Monthly | Single Neural Sleeve - Year 2+ |
| Subscription | Monthly | Dual Neural Sleeve - Year 2+ |
| One time/ perpetual license | Pay-as-you-go | Refurbished Neural Sleeve |
| Unit Pricing | Pay-as-you-go | Side Exchange |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
CIONIC product offering
Product offeringCore offering
CIONIC designs, manufactures, and sells the FDA-cleared Neural Sleeve, a wearable neurotechnology garment that uses AI-powered MultiStim functional electrical stimulation combined with continuous afferent stimulation to improve walking in individuals with neurological conditions such as multiple sclerosis, cerebral palsy, stroke, spinal cord injury, and traumatic brain injury. The system is delivered through an online assessment and prescription workflow, with the Cionic companion app for personalized control and ongoing support from Mobility Specialists, sold via a hardware-plus-subscription model.
Product overview
CIONIC offers a unified bionic mobility system consisting of the Neural Sleeve (a wearable neurotech device combining FDA-cleared Functional Electrical Stimulation with AI-powered real-time gait analysis), the companion Cionic App (for personalized control and progress tracking), and Mobility Specialists (for onboarding and ongoing support). The company also offers a separate Cionic Research Kit for academic and clinical researchers conducting human mobility studies.
Differentiator
Problem solved
Functional benefit
Products and services
- Neural Sleeve 2 FDA-cleared bionic clothing garment that uses AI-powered MultiStim technology combining functional electrical stimulation and continuous afferent stimulation to improve walking, activate functional muscle movement, and relax muscle spasms for individuals with neurological conditions including MS, cerebral palsy, stroke, and spinal cord injury.
- Certified Refurbished Neural Sleeve One-time-purchase refurbished Neural Sleeve at $875 that includes the device, 3 months of Mobility Specialist service, electrode supply, and app access, with the option to enroll in the ongoing subscription afterward. Intended for cost-sensitive consumers who want hardware access without committing to the full subscription.
- Cionic App iOS and Android companion application for Neural Sleeve users that delivers progress measurement, personalized muscle stimulation control, and a growing library of training programs. Sold as part of the Neural Sleeve subscription bundle.
- Mobility Specialist Support Service Expert-led onboarding, program tailoring, and ongoing support delivered by CIONIC's Mobility Specialists to Neural Sleeve users. Included with active subscriptions and available à la carte for non-subscribers.
- Cionic Research Kit Standalone research platform for academic and clinical investigators conducting human mobility studies, providing hardware sensors (IMU kinematics up to 400 Hz, sEMG up to 4 kHz), mobile and web applications, a Jupyter analysis environment, HIPAA-compliant infrastructure, and SDKs/REST APIs. Targets research institutions such as Shirley Ryan AbilityLab and Stanford University.
Quantifiable outcome
- 94% of participants experienced improved gait
- +7 more outcomes
Companies that use CIONIC
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
CIONIC technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature6 records
CIONIC partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- Lovell Government ServicescorePartnership with veteran-owned business Lovell Government Services to enhance veterans' access to the Cionic Neural Sleeve through federal healthcare systems. Aims to improve mobility for veterans with neurological conditions including MS.
- Shirley Ryan AbilityLabcoreClinical and research partnership with leading rehabilitation research hospital for evidence development and validation.
- Stanford UniversitycoreAcademic research partnership for human motion and gait research.
- National MS SocietycorePartnership with leading MS advocacy organization for research and community support.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
CIONIC competitors and assessment
Company assessmentDirect peers
- Bioness: Bioness is a direct competitor in functional electrical stimulation devices for foot drop and gait rehabilitation, with FDA-cleared L300 Go and H200 products. Both companies target the same neurological mobility patient population with similar FES technology, though CIONIC differentiates with AI-driven adaptive multi-channel stimulation.
- Saebo: Saebo develops rehabilitation devices for stroke, neurological injury, and mobility impairment, including functional electrical stimulation products and orthoses. Comparable because both companies target the same neurological patient population with clinical evidence-based rehabilitation technology.
- Compex: Compex (DJO/Enovis) is a leading brand in electrical muscle stimulation devices for rehabilitation, sports performance, and pain management. Comparable because both offer neuromuscular electrical stimulation technology for muscle activation and recovery, though Compex is more consumer/clinical-rehab oriented and CIONIC is more neurological-condition focused.
- Hasomed: Hasomed develops the RehaMove functional electrical stimulation device for gait rehabilitation and therapy in neurological patients. Comparable as a direct FES competitor in the same patient population, though primarily a clinical/rehab setting device vs. CIONIC's consumer wearable approach.
Broad incumbents
- Ottobock: Ottobock is a global incumbent in prosthetics, orthotics, and rehabilitation technology with FES products (e.g., L300 Go via acquisition) and broader mobility aids. Comparable because they sell competing FES solutions and complementary mobility devices through established clinical channels and reimbursement networks.
- Enovis (DJO): Enovis (formerly DJO) is a large medical device company with a broad portfolio in orthopedic, rehabilitation, and pain management products including FES devices. Comparable as a broader incumbent competing in the same FES/rehabilitation space with established payer relationships and clinical sales channels.
- LivaNova: LivaNova is a global neuromodulation and cardiac surgery company with VNS (vagus nerve stimulation) therapy for epilepsy and depression. Comparable as a broader incumbent in neuromodulation technology applied to neurological conditions, though focused on implantable vagus nerve stimulation rather than wearable FES.
Emerging players
- Ekso Bionics: Ekso Bionics builds robotic exoskeletons for rehabilitation and mobility assistance in stroke, spinal cord injury, and multiple sclerosis. Comparable because they target the same neurological mobility patient population, though using mechanical exoskeleton technology rather than FES-based wearable stimulation.
- ReWalk Robotics: ReWalk Robotics develops wearable robotic exoskeletons for individuals with spinal cord injury and other mobility impairments. Comparable in targeting neurological mobility patients with FDA-cleared wearable technology, though using a different modality (powered exoskeleton vs. FES).
- NeuroPace: NeuroPace develops implantable neurostimulation devices (RNS System) for epilepsy with closed-loop responsive stimulation. Comparable as a neurotechnology company applying AI-driven adaptive stimulation to neurological conditions, though in an implantable form factor for a different indication.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
CIONIC social profiles
Digital presenceCIONIC compliance and trust
Trust signalCompliance2 records
CIONIC financial estimates
Financial estimateRevenue estimate
Valuation estimate
CIONIC leadership team
Management profileNumber of profiles
Profiles1 record
CIONIC funding detail
Funding detailFunding overview
Funding rounds5 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CIONIC M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CIONIC
What does CIONIC do?
CIONIC designs, manufactures, and sells the FDA-cleared Neural Sleeve, a wearable neurotechnology garment that uses AI-powered MultiStim functional electrical stimulation combined with continuous afferent stimulation to improve walking in individuals with neurological conditions such as multiple sclerosis, cerebral palsy, stroke, spinal cord injury, and traumatic brain injury. The system is delivered through an online assessment and prescription workflow, with the Cionic companion app for personalized control and ongoing support from Mobility Specialists, sold via a hardware-plus-subscription model.
Is CIONIC a public or private company?
CIONIC is a private company. It is classified as venture growth investor backed and is currently operating.
When was CIONIC founded?
CIONIC was founded in 2020. It employs 11 to 50 people.
Where is CIONIC based?
CIONIC is headquartered in San Francisco, United States, in the North America region.
How does CIONIC make money?
Four revenue lines are on record. Neural Sleeve Hardware Sales are the primary driver. The others are subscription Services, refurbished Device Sales and professional Services.
Who are CIONIC's main competitors?
Direct peers on record are Bioness, Saebo, Compex and Hasomed. Broad incumbents are Ottobock, Enovis (DJO) and LivaNova. Emerging players are Ekso Bionics, ReWalk Robotics and NeuroPace.
Does CIONIC have an API?
No public API is recorded for CIONIC.
What industry is CIONIC in?
CIONIC's product category is Wearable Neurotechnology / Medical Mobility Devices. Its primary akta.pro industry code is HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices), with a secondary code of HDACAFAL, Assistive & Accessibility Input Devices (Switches, Adaptive Controllers, Braille Keyboards). Its NAICS code is 334510 and its SIC code is 3845.